Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis Meeting Abstract
| Authors: | Moore, Z. R.; Rimner, A.; Lobaugh, S.; Geyer, A.; Gelblum, D. Y.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J. E.; Zauderer, M. G.; Rudin, C. M.; Vander Els, N.; Chawla, M.; Jones, D. R.; Sopka, D. M.; Mak, R.; Liao, Z.; Gomez, D. R.; Zhang, Z.; Paik, P. |
| Abstract Title: | Randomized, phase II, placebo-controlled trial of nintedanib for the treatment of radiation pneumonitis |
| Meeting Title: | European Lung Cancer Congress (ELCC) 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Mar 30-Apr 2 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-04-01 |
| Start Page: | S118 |
| Language: | English |
| ACCESSION: | WOS:000778453100194 |
| DOI: | 10.1016/j.annonc.2022.02.117 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 192P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
